Clinical Trials Directory

Trials / Terminated

TerminatedNCT00419120

Augmentation Cystoplasty Using an Autologous Neo-Bladder

An Open-Label Multicenter Study of Augmentation Cystoplasty Using an Autologous Neo-Bladder Construct in Subjects With Spina Bifida

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Tengion · Industry
Sex
All
Age
3 Years – 21 Years
Healthy volunteers
Not accepted

Summary

Subjects with neurogenic bladder secondary to spina bifida refractory to medical treatment will be enrolled. The hypothesis is that augmentation cystoplasty using an autologous neo-bladder construct will significantly increase bladder compliance.

Detailed description

Subjects with neurogenic bladder secondary to spina bifida (myelodysplasia) that is refractory to medical treatment and require augmentation cystoplasty will be enrolled. The hypothesis is that augmentation cystoplasty using an autologous neo-bladder construct will significantly increase bladder compliance.

Conditions

Interventions

TypeNameDescription
BIOLOGICALAutologous neo bladder constructaugmentation cystoplasty with autologous neo-bladder construct

Timeline

Start date
2006-12-01
Primary completion
2008-10-01
Completion
2011-04-01
First posted
2007-01-08
Last updated
2015-11-30
Results posted
2010-06-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00419120. Inclusion in this directory is not an endorsement.